MO068EFFICACY AND SAFETY OF MIGALASTAT, AN ORAL PHARMACOLOGICAL CHAPERONE FOR FABRY DISEASE: RENAL FINDINGS FROM TWO RANDOMIZED PHASE 3 STUDIES (FACETS AND ATTRACT)
Bibliographic record
Abstract
INTRODUCTION AND AIMS: Fabry disease is an X-linked disorder of lysosomal α-galactosidase A (α-Gal A) deficiency, leading to substrate accumulation, multiorgan disease, and progressive decline in renal function. Accumulation of GL-3 in the kidney is a known consequence of Fabry disease. We examined whether administration of migalastat, an oral pharmacological chaperone that induces proper folding of specific mutant forms of α-Gal A and increases trafficking to lysosomes, helps stabilize renal function in patients with Fabry disease. METHODS: Two randomized phase 3 studies were conducted for migalastat 150 mg QOD. FACETS (011, NCT00985301) was a 24-month trial, including a 6-month double-blind, placebo-controlled period, in 67 enzyme replacement therapy (ERT)-naive patients. ATTRACT (012, NCT01218659) was an active-controlled, 18-month trial in 57 ERT-experienced patients with a 12-month open-label extension (OLE). Efficacy analyses focused on patients with amenable mutations (FACETS, n=50; ATTRACT, n=53). A post hoc analysis examined the eGFR annualized rate of change from baseline in the range of 60 to <90 or >90 mL/min/1.73 m2; the range of 30 to <60 mL/min/1.73 m2 was not included due to the low number of patients in this group. RESULTS: In FACETS, analyses revealed statistically significant reductions in kidney interstitial capillary GL-3 from months 0 to 6 (placebo-controlled; P=0.008) and months 6 to 12 (P=0.014). Over 24 months, the annualized rate of change in eGFRCKD-EPI ± SD with migalastat was −0.3±4.2 . The annualized rate of change ±SD for eGFR in the range of 60 to <90 mL/min/1.73 m2 (−0.8±4.16) was comparable to the rate in the range of ≥90 mL/min/1.73 m2 (0.2±4.11). During the 18-month controlled period of ATTRACT, the annualized means ± SD for eGFR for migalastat (−0.40±4.3) and ERT (−1.03±7.4) were comparable. The annualized rates of change in eGFR ± SD in the range of 60 to <90 mL/min/1.73 m2 for migalastat and ERT were −0.2±5.32 and −7.3±15.90, respectively; the annualized rates in the range of ≥90 mL/min/1.73 m2 were −2.0±2.15 and −2.1±5.30. Predefined renal events occurred in 24% and 33% of patients on migalastat and ERT, respectively. During the 12-month OLE, eGFR remained stable. CONCLUSIONS: In FACETS and ATTRACT, renal function remained stable with migalastat across patient subgroups. Migalastat has promise as a first-in-class oral chaperone for patients with Fabry disease with amenable mutations.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame machine prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.
Distilled classifier scores by category (both heads)
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.005 | 0.002 |
| Meta-epidemiology (narrow) | 0.001 | 0.001 |
| Meta-epidemiology (broad) | 0.003 | 0.002 |
| Bibliometrics | 0.000 | 0.000 |
| Science and technology studies | 0.000 | 0.001 |
| Scholarly communication | 0.001 | 0.001 |
| Open science | 0.001 | 0.000 |
| Research integrity | 0.002 | 0.002 |
| Insufficient payload (model declined to judge) | 0.005 | 0.001 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".